DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Sertraline and Naltrexone for Alcohol Dependence

Information source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Alcoholism

Intervention: naltrexone (Revia) (Drug); sertraline (Zoloft) (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Summary

This study is a double-blind, placebo-controlled outpatient trial to improve, through the addition of sertraline (Zoloft), the abstinence and relapse rates in alcohol- dependent individuals currently taking naltrexone (Revia).

Clinical Details

Official title: Sertraline and Naltrexone for Alcohol Dependents

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study

Eligibility

Minimum age: 18 Years. Maximum age: 55 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Meets the criteria for alcohol dependence.

- Abstinent from alcohol for a period of at least 5 days and not greater than 30 days.

- Able to read English and complete study evaluations.

- A stable residence and a telephone to ensure that subjects can be located during the

study.

Exclusion Criteria:

- Currently meets criteria for substance abuse or dependence with the exception of

nicotine dependence.

- Current use of disulfiram (Antabuse) or a MAO Inhibitor.

- Psychotic or otherwise severely psychiatrically disabled (i. e., depressed, suicidal,

current mania).

- Major depression at the time of assessment.

- Previous treatment with naltrexone (Revia) for alcohol dependence.

- Significant underlying medical conditions such as cerebral, renal, thyroid, or cardiac

disease.

- Abstinent longer than 30 days prior to admission to program.

- Hepatocellular disease or elevated bilirubin levels.

- Females who are pregnant, nursing, or not using a reliable method of birth control.

Locations and Contacts

Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, United States
Additional Information


Ending date: September 2002
Last updated: June 23, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009